In a recent mouse model of allergic conjunctivitis, stimulation and activation of the Th17 cytokines IL-17A and IL-17F, as well as the specific transcription factor RORγt, suggest that developmental enhancement can exacerbate Th2 dominant allergic inflammation in conjunctivitis (52). This evidence concerns the gene IL17A and conjunctivitis.